News Events
March 26, 2010
Escape develops a novel biomaterial for tissue engineering applications.
Escape Therapeutics announces the online publication of its research on MorphoGel™,
a novel hybrid hydrogel biomaterial for use in tissue engineering applications. The article
is titled "Support of human adipose-derived mesenchymal stem cell multipotency by a
poloxamer-octapeptide hybrid hydrogel." The study was led by Dr. Hantash, Escape's CEO,
and his team of scientists. The development of new biological materials, particularly
those capable of serving as permissive substrates for cell growth, differentiation, and
biological function, is a key area for advancing medical
technology. In this study, MorphoGel™ significantly increased human adipose-derived
mesenchymal stem cell proliferation rates while supporting multipotency both in vitro and
in vivo.
Escape's study shows that MorphoGel™ maintains improved mechanical properties and
bioactivity relative to its individual constituents, supporting its potential use as a stem
cell scaffold in soft tissue engineering applications.